Previous 10 | Next 10 |
2023-04-14 17:01:46 ET LivaNova ( NASDAQ: LIVN ) on Friday announced the resignation of its CEO and preliminary Q1 revenue that was above consensus estimates. Damien McDonald resigned as LIVN's CEO, the company said in a statement , with chair of the board William Kozy app...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced that Damien McDonald has resigned as Chief Executive Officer. Effective immediately, Chair of the Board William A. Kozy is appointed interim CEO to help the executive leadership team maintain ...
2023-04-13 03:45:00 ET Summary We are value investors. In constructing portfolios for our clients, we seek out companies that we believe are trading in the market at significant discounts to their underlying value. These businesses must offer significant profit potential and be run by...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its first-quarter 2023 results on Wednesday, May 3, 2023 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its first-quarter 2023 results prior to th...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Essenz™ Heart-Lung Machine (HLM). With FDA clearance, LivaNova initiates the commercial launch of Essenz in ...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced Damien McDonald, Chief Executive Officer, will present in a fireside chat at the Barclays Global Healthcare Conference in Miami, Florida. The presentation will take place at 9 a.m. Eastern Tim...
2023-03-05 22:12:31 ET Summary David Einhorn's 13F stock portfolio value increased from $1.41B to $1.44B this quarter. Greenlight added Tenet Healthcare and increased Kyndryl Holdings, Southwestern Energy, and Global Payments during the quarter. The largest three positions are...
LivaNova (LIVN ) rose 2.2% amid some vague takeover speculation following the company's Q4 results and some amendments for executive compensation in a potential acquisition. LivaNova ( NASDAQ: LIVN ) disclosed on Wednesday in a filing that it's compensation committee amended s...
LivaNova PLC (LIVN) Q4 2022 Results Earnings Conference Call February 22, 2023, 08:00 AM ET Company Participants Matthew Dodds - Senior Vice President, Corporate Development Damien McDonald - Chief Executive Officer Alex Shvartsburg - Chief Financial Officer Conf...
The following slide deck was published by LivaNova PLC in conjunction with their 2022 Q4 earnings call. For further details see: LivaNova PLC 2022 Q4 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
2024-06-23 00:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its second-quarter 2024 results on Wednesday, July 31, 2024 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its second-quarter 2024 results prior to the call. ...
2024-06-06 11:00:14 ET Rick Wise from Stifel Nicolaus issued a price target of $70.00 for LIVN on 2024-06-06 09:52:00. The adjusted price target was set to $70.00. At the time of the announcement, LIVN was trading at $53.16. The overall price target consensus is at $69.5...